Biotechnology
The Biotechnology industry has a total of 606 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.22 billion.
Market Cap
1.11T
Revenue
105.22B
Profits
-42.54B
PE Ratio
n/a
Profit Margin
-40.43%
Dividend Yield
0.04%
606 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 111.76B | -0.35% | 247,197 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 71.76B | -0.55% | 203,708 | 14.25B |
| 3 | ARGX | argenx SE | 55.71B | -0.73% | 148,370 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 55.66B | -2.02% | 301,517 | 3.21B |
| 5 | INSM | Insmed Incorporated | 41.72B | -0.46% | 658,199 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 35.55B | -1.61% | 83,521 | 4.97B |
| 7 | BNTX | BioNTech SE | 23.13B | -1.11% | 506,455 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.09B | -1.06% | 851,597 | 2.35B |
| 9 | GMAB | Genmab A/S | 19.70B | -2.00% | 480,271 | 3.85B |
| 10 | INCY | Incyte Corporation | 19.03B | 0.22% | 541,939 | 4.81B |
| 11 | RVMD | Revolution Medicines, Inc. | 15.13B | -2.26% | 925,687 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 14.49B | -0.76% | 1,205,790 | 20.33M |
| 13 | BBIO | BridgeBio Pharma, Inc. | 14.14B | -1.13% | 345,653 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 13.63B | -5.07% | 1,312,680 | - |
| 15 | IONS | Ionis Pharmaceuticals, Inc. | 12.89B | -2.34% | 754,448 | 966.96M |
| 16 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.77B | -1.14% | 46,397 | 740.64M |
| 17 | ASND | Ascendis Pharma A/S | 12.24B | -3.27% | 230,662 | 758.59M |
| 18 | EXEL | Exelixis, Inc. | 11.23B | -1.07% | 719,410 | 2.29B |
| 19 | MRNA | Moderna, Inc. | 10.97B | 0.39% | 2,961,403 | 2.23B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.76B | 0.21% | 1,611,553 | 20.87M |
| 21 | JAZZ | Jazz Pharmaceuticals plc | 10.30B | 0.29% | 130,327 | 4.16B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.28B | 0.41% | 334,500 | 3.09B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.37B | 0.57% | 1,186,507 | 829.45M |
| 24 | TECH | Bio-Techne Corporation | 9.29B | -1.06% | 366,487 | 1.22B |
| 25 | CORT | Corcept Therapeutics Incorporated | 8.82B | 1.05% | 231,539 | 741.17M |
| 26 | ABVX | ABIVAX Société Anonyme | 8.77B | 4.82% | 998,302 | 7.07M |
| 27 | NUVL | Nuvalent, Inc. | 8.30B | -0.96% | 129,085 | - |
| 28 | CAI | Caris Life Sciences, Inc. | 7.71B | -3.63% | 1,117,135 | 649.06M |
| 29 | CYTK | Cytokinetics, Incorporated | 7.70B | -1.86% | 407,321 | 87.21M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.36B | -0.46% | 508,839 | 1.24B |
| 31 | AXSM | Axsome Therapeutics, Inc. | 7.35B | -1.16% | 95,307 | 561.26M |
| 32 | MRUS | Merus N.V. | 7.31B | 0.08% | 616,448 | 56.61M |
| 33 | CDTX | Cidara Therapeutics, Inc. | 6.92B | 0.01% | 359,758 | 302.00K |
| 34 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.91B | -1.53% | 144,873 | 174.33M |
| 35 | KRYS | Krystal Biotech, Inc. | 6.80B | 0.16% | 145,782 | 373.16M |
| 36 | PRAX | Praxis Precision Medicines, Inc. | 6.63B | -2.21% | 226,170 | 7.46M |
| 37 | KYMR | Kymera Therapeutics, Inc. | 6.31B | -6.96% | 1,139,488 | 43.74M |
| 38 | PTCT | PTC Therapeutics, Inc. | 5.99B | -3.04% | 269,831 | 1.78B |
| 39 | PCVX | Vaxcyte, Inc. | 5.95B | -1.56% | 249,702 | - |
| 40 | COGT | Cogent Biosciences, Inc. | 5.84B | -4.71% | 792,610 | - |
| 41 | PTGX | Protagonist Therapeutics, Inc. | 5.68B | 0.64% | 255,157 | 209.22M |
| 42 | CRSP | CRISPR Therapeutics AG | 5.50B | 0.56% | 578,359 | 38.34M |
| 43 | BLTE | Belite Bio, Inc | 5.20B | -0.49% | 82,092 | - |
| 44 | APGE | Apogee Therapeutics, Inc. | 5.16B | 0.46% | 255,442 | - |
| 45 | CELC | Celcuity Inc. | 4.89B | 1.60% | 347,135 | - |
| 46 | ADMA | ADMA Biologics, Inc. | 4.71B | 2.11% | 673,934 | 488.56M |
| 47 | ACAD | ACADIA Pharmaceuticals Inc. | 4.65B | 2.77% | 732,780 | 1.05B |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.63B | 0.38% | 643,036 | - |
| 49 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.59B | 1.98% | 399,146 | 1.54M |
| 50 | LEGN | Legend Biotech Corporation | 4.56B | -5.53% | 2,481,938 | 909.05M |
| 51 | TGTX | TG Therapeutics, Inc. | 4.52B | 0.23% | 299,792 | 531.90M |
| 52 | AKRO | Akero Therapeutics, Inc. | 4.50B | 0.09% | - | - |
| 53 | VKTX | Viking Therapeutics, Inc. | 4.26B | -0.76% | 672,113 | - |
| 54 | CNTA | Centessa Pharmaceuticals plc | 4.19B | -2.75% | 339,838 | 15.00M |
| 55 | GPCR | Structure Therapeutics Inc. | 4.18B | -1.54% | 1,912,830 | - |
| 56 | ACLX | Arcellx, Inc. | 4.17B | -2.54% | 405,161 | 35.90M |
| 57 | IMVT | Immunovant, Inc. | 4.05B | -0.39% | 256,866 | - |
| 58 | NAMS | NewAmsterdam Pharma Company N.V. | 4.03B | -0.50% | 203,357 | 35.24M |
| 59 | TERN | Terns Pharmaceuticals, Inc. | 3.75B | 3.41% | 3,101,597 | - |
| 60 | ARQT | Arcutis Biotherapeutics, Inc. | 3.68B | -3.24% | 663,552 | 317.93M |
| 61 | TARS | Tarsus Pharmaceuticals, Inc. | 3.55B | 1.70% | 141,331 | 366.10M |
| 62 | RARE | Ultragenyx Pharmaceutical Inc. | 3.46B | -1.40% | 350,373 | 630.60M |
| 63 | IRON | Disc Medicine, Inc. | 3.45B | -0.90% | 127,679 | - |
| 64 | CGON | CG Oncology, Inc. | 3.43B | -0.54% | 220,026 | 2.17M |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.42B | -0.56% | 163,587 | 7.50M |
| 66 | MIRM | Mirum Pharmaceuticals, Inc. | 3.40B | -2.45% | 244,403 | 471.79M |
| 67 | OCUL | Ocular Therapeutix, Inc. | 3.35B | -2.36% | 1,826,652 | 55.78M |
| 68 | WVE | Wave Life Sciences Ltd. | 3.34B | 7.94% | 19,891,006 | 109.23M |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.21B | -1.02% | 37,456 | 664.23M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.14B | -1.57% | 384,840 | 240.00M |
| 71 | TVTX | Travere Therapeutics, Inc. | 3.13B | 1.90% | 315,244 | 435.83M |
| 72 | FOLD | Amicus Therapeutics, Inc. | 3.05B | 0.30% | 1,164,409 | 598.70M |
| 73 | VRDN | Viridian Therapeutics, Inc. | 3.05B | 0.13% | 344,262 | 70.79M |
| 74 | LQDA | Liquidia Corporation | 3.04B | -0.29% | 315,583 | 69.22M |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 3.03B | -2.24% | 389,277 | 214.83M |
| 76 | MLYS | Mineralys Therapeutics, Inc. | 3.02B | -0.21% | 244,362 | - |
| 77 | APLS | Apellis Pharmaceuticals, Inc. | 3.01B | 0.13% | 350,594 | 1.02B |
| 78 | DNLI | Denali Therapeutics Inc. | 2.88B | -0.15% | 247,621 | - |
| 79 | NUVB | Nuvation Bio Inc. | 2.85B | -3.09% | 1,281,325 | 26.75M |
| 80 | VERA | Vera Therapeutics, Inc. | 2.81B | -2.31% | 747,424 | - |
| 81 | AAPG | Ascentage Pharma Group International | 2.81B | -4.82% | 595 | 54.52M |
| 82 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.80B | -1.77% | 232,536 | 578.20M |
| 83 | SLNO | Soleno Therapeutics, Inc. | 2.78B | 1.02% | 213,494 | 98.68M |
| 84 | DYN | Dyne Therapeutics, Inc. | 2.73B | -13.78% | 2,691,472 | - |
| 85 | SYRE | Spyre Therapeutics, Inc. | 2.68B | -0.32% | 239,160 | - |
| 86 | BEAM | Beam Therapeutics Inc. | 2.66B | -0.66% | 362,043 | 55.70M |
| 87 | RXRX | Recursion Pharmaceuticals, Inc. | 2.54B | 1.24% | 8,571,071 | 43.69M |
| 88 | EWTX | Edgewise Therapeutics, Inc. | 2.52B | 1.04% | 391,023 | - |
| 89 | MESO | Mesoblast Limited | 2.39B | 5.47% | 128,125 | 17.20M |
| 90 | SRPT | Sarepta Therapeutics, Inc. | 2.33B | 1.69% | 782,015 | 2.41B |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 2.28B | 1.59% | 397,636 | 825.94M |
| 92 | ADPT | Adaptive Biotechnologies Corporation | 2.27B | -0.47% | 1,402,393 | 252.75M |
| 93 | IBRX | ImmunityBio, Inc. | 2.21B | -0.88% | 3,291,374 | 82.56M |
| 94 | NRIX | Nurix Therapeutics, Inc. | 2.12B | -2.65% | 790,073 | 83.69M |
| 95 | ZLAB | Zai Lab Limited | 2.10B | -0.94% | 97,115 | 441.63M |
| 96 | ZBIO | Zenas BioPharma, Inc. | 2.09B | -1.00% | 53,770 | 15.00M |
| 97 | GLPG | Galapagos NV | 2.08B | 0.83% | 30,717 | 336.64M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.05B | -0.77% | 275,166 | 265.81M |
| 99 | OLMA | Olema Pharmaceuticals, Inc. | 2.05B | -7.01% | 896,530 | - |
| 100 | MAZE | Maze Therapeutics, Inc. | 1.97B | -1.06% | 94,564 | 2.50M |
| 101 | IMCR | Immunocore Holdings plc | 1.93B | 0.29% | 350,574 | 379.59M |
| 102 | ZYME | Zymeworks Inc. | 1.93B | -2.50% | 231,422 | 134.48M |
| 103 | VCEL | Vericel Corporation | 1.92B | 1.98% | 230,398 | 258.72M |
| 104 | CLDX | Celldex Therapeutics, Inc. | 1.92B | -3.09% | 863,331 | 2.60M |
| 105 | DNTH | Dianthus Therapeutics, Inc. | 1.87B | 0.02% | 108,578 | 3.08M |
| 106 | STOK | Stoke Therapeutics, Inc. | 1.86B | -1.24% | 193,459 | 205.63M |
| 107 | SION | Sionna Therapeutics, Inc. | 1.85B | 2.01% | 43,362 | - |
| 108 | MNKD | MannKind Corporation | 1.77B | 2.58% | 868,213 | 313.79M |
| 109 | IMNM | Immunome, Inc. | 1.76B | -2.06% | 177,518 | 9.68M |
| 110 | SNDX | Syndax Pharmaceuticals, Inc. | 1.73B | -0.15% | 515,698 | 111.30M |
| 111 | TRVI | Trevi Therapeutics, Inc. | 1.71B | 3.00% | 388,180 | - |
| 112 | PHVS | Pharvaris N.V. | 1.62B | -1.46% | 91,285 | - |
| 113 | ATAI | Atai Beckley N.V. | 1.61B | -0.45% | 751,047 | 3.02M |
| 114 | AGIO | Agios Pharmaceuticals, Inc. | 1.60B | 0.57% | 274,671 | 44.79M |
| 115 | CAPR | Capricor Therapeutics, Inc. | 1.59B | -3.26% | 874,369 | 11.13M |
| 116 | SVRA | Savara Inc. | 1.56B | 0.15% | 376,559 | - |
| 117 | INVA | Innoviva, Inc. | 1.56B | -0.67% | 116,200 | 388.52M |
| 118 | UPB | Upstream Bio, Inc. | 1.53B | -2.31% | 121,516 | 2.80M |
| 119 | ORKA | Oruka Therapeutics, Inc. | 1.52B | -0.37% | 89,545 | - |
| 120 | TSHA | Taysha Gene Therapies, Inc. | 1.48B | -1.10% | 1,293,703 | 6.31M |
| 121 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.46B | -0.79% | 421,979 | 42.34M |
| 122 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.46B | -2.63% | 245,326 | -665.00K |
| 123 | ARDX | Ardelyx, Inc. | 1.44B | 0.68% | 790,240 | 398.23M |
| 124 | RAPP | Rapport Therapeutics, Inc. | 1.38B | -3.75% | 179,259 | - |
| 125 | KOD | Kodiak Sciences Inc. | 1.35B | -2.16% | 183,116 | - |
| 126 | FTRE | Fortrea Holdings Inc. | 1.35B | -1.35% | 282,296 | 2.76B |
| 127 | BHVN | Biohaven Ltd. | 1.34B | -4.46% | 995,775 | - |
| 128 | MBX | MBX Biosciences, Inc. | 1.33B | -5.77% | 210,195 | - |
| 129 | RLAY | Relay Therapeutics, Inc. | 1.33B | 0.20% | 593,911 | 8.36M |
| 130 | QURE | uniQure N.V. | 1.32B | -2.39% | 592,793 | 15.75M |
| 131 | INBX | Inhibrx Biosciences, Inc. | 1.32B | -2.78% | 36,722 | 1.40M |
| 132 | PGEN | Precigen, Inc. | 1.30B | -0.54% | 742,531 | 6.31M |
| 133 | IMTX | Immatics N.V. | 1.24B | -0.39% | 82,514 | 99.45M |
| 134 | XNCR | Xencor, Inc. | 1.24B | -1.70% | 133,080 | 150.13M |
| 135 | TNGX | Tango Therapeutics, Inc. | 1.24B | -4.17% | 538,727 | 66.50M |
| 136 | MNMD | Mind Medicine (MindMed) Inc. | 1.23B | -4.23% | 636,379 | - |
| 137 | ANAB | AnaptysBio, Inc. | 1.22B | -0.88% | 54,476 | 169.47M |
| 138 | XERS | Xeris Biopharma Holdings, Inc. | 1.19B | 2.29% | 620,603 | 266.14M |
| 139 | OCS | Oculis Holding AG | 1.19B | -0.34% | 11,212 | 992.00K |
| 140 | SANA | Sana Biotechnology, Inc. | 1.19B | -3.89% | 1,385,044 | - |
| 141 | TYRA | Tyra Biosciences, Inc. | 1.18B | -3.16% | 141,448 | - |
| 142 | PVLA | Palvella Therapeutics, Inc. | 1.17B | -1.76% | 38,190 | - |
| 143 | NKTR | Nektar Therapeutics | 1.17B | 0.65% | 98,949 | 62.60M |
| 144 | CVAC | CureVac N.V. | 1.16B | -1.15% | 420,749 | 83.00M |
| 145 | PHAR | Pharming Group N.V. | 1.16B | 0.29% | 3,867 | 362.27M |
| 146 | GLUE | Monte Rosa Therapeutics, Inc. | 1.15B | -1.29% | 152,109 | 181.54M |
| 147 | SEPN | Septerna, Inc. | 1.13B | -2.66% | 56,959 | 22.05M |
| 148 | ALMS | Alumis Inc. | 1.13B | -3.23% | 350,001 | 22.12M |
| 149 | ELVN | Enliven Therapeutics, Inc. | 1.12B | -7.80% | 791,707 | - |
| 150 | NVAX | Novavax, Inc. | 1.11B | 0.59% | 721,241 | 1.06B |
| 151 | NTLA | Intellia Therapeutics, Inc. | 1.10B | 0.95% | 1,177,593 | 57.53M |
| 152 | ABCL | AbCellera Biologics Inc. | 1.10B | 1.95% | 730,322 | 35.33M |
| 153 | URGN | UroGen Pharma Ltd. | 1.08B | 0.13% | 126,989 | 96.52M |
| 154 | MLTX | MoonLake Immunotherapeutics | 1.04B | -3.19% | 906,372 | - |
| 155 | BCAX | Bicara Therapeutics Inc. | 1.04B | 0.58% | 111,751 | - |
| 156 | MDXG | MiMedx Group, Inc. | 1.03B | 4.04% | 330,317 | 393.44M |
| 157 | AVBP | ArriVent BioPharma, Inc. | 1.03B | -0.52% | 80,264 | - |
| 158 | NBTX | Nanobiotix S.A. | 1.03B | 2.59% | 11,033 | 11.93M |
| 159 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.01B | -3.61% | 64,263 | - |
| 160 | SPRY | ARS Pharmaceuticals, Inc. | 1.01B | 2.45% | 639,913 | 142.77M |
| 161 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | -2.48% | 248,319 | 147.19M |
| 162 | ORIC | ORIC Pharmaceuticals, Inc. | 986.55M | -3.71% | 384,896 | - |
| 163 | RAPT | RAPT Therapeutics, Inc. | 972.65M | 0.46% | 44,492 | - |
| 164 | JANX | Janux Therapeutics, Inc. | 971.99M | -2.53% | 657,163 | 10.00M |
| 165 | RZLT | Rezolute, Inc. | 963.44M | 2.16% | 510,694 | - |
| 166 | KURA | Kura Oncology, Inc. | 962.41M | -4.98% | 856,079 | 104.03M |
| 167 | YDES | YD Bio Limited | 952.83M | -12.13% | 61,650 | 510.36K |
| 168 | CMPX | Compass Therapeutics, Inc. | 951.56M | -0.19% | 243,225 | 850.00K |
| 169 | ERAS | Erasca, Inc. | 950.43M | 0.30% | 467,738 | - |
| 170 | CRMD | CorMedix Inc. | 943.89M | 6.39% | 2,076,389 | 214.30M |
| 171 | VIR | Vir Biotechnology, Inc. | 940.49M | 2.74% | 444,190 | 16.86M |
| 172 | MRVI | Maravai LifeSciences Holdings, Inc. | 925.66M | 0.28% | 206,040 | 192.44M |
| 173 | IOVA | Iovance Biotherapeutics, Inc. | 909.06M | -0.87% | 2,646,056 | 250.43M |
| 174 | GHRS | GH Research PLC | 908.73M | 0.14% | 43,412 | - |
| 175 | TBPH | Theravance Biopharma, Inc. | 908.05M | -1.10% | 85,555 | 80.33M |
| 176 | ABUS | Arbutus Biopharma Corporation | 867.38M | -0.22% | 163,986 | 14.61M |
| 177 | DAWN | Day One Biopharmaceuticals, Inc. | 864.53M | -2.55% | 848,115 | 133.67M |
| 178 | ARVN | Arvinas, Inc. | 851.61M | -0.45% | 233,699 | 312.30M |
| 179 | KALV | KalVista Pharmaceuticals, Inc. | 837.05M | -1.78% | 411,914 | 1.43M |
| 180 | REPL | Replimune Group, Inc. | 829.15M | -1.49% | 443,807 | - |
| 181 | MPLT | MapLight Therapeutics, Inc. | 812.60M | 0.92% | 51,141 | - |
| 182 | OMER | Omeros Corporation | 810.39M | 0.26% | 543,509 | - |
| 183 | GOSS | Gossamer Bio, Inc. | 802.00M | 1.61% | 694,134 | 44.05M |
| 184 | LENZ | LENZ Therapeutics, Inc. | 799.15M | -4.38% | 145,356 | 17.50M |
| 185 | GERN | Geron Corporation | 797.94M | -1.57% | 2,088,136 | 183.40M |
| 186 | VSTM | Verastem, Inc. | 789.57M | -0.20% | 202,871 | 13.38M |
| 187 | RIGL | Rigel Pharmaceuticals, Inc. | 781.23M | -0.83% | 132,230 | 282.08M |
| 188 | IVA | Inventiva S.A. | 776.73M | -0.23% | 48,655 | 19.93M |
| 189 | VALN | Valneva SE | 772.07M | -0.45% | 3,713 | 211.09M |
| 190 | CGEM | Cullinan Therapeutics, Inc. | 747.91M | 1.77% | 595,749 | - |
| 191 | ATXS | Astria Therapeutics, Inc. | 743.82M | 0.23% | 486,414 | 706.00K |
| 192 | PRME | Prime Medicine, Inc. | 741.79M | -0.48% | 1,295,046 | 5.98M |
| 193 | ANNX | Annexon, Inc. | 733.35M | 1.23% | 952,044 | - |
| 194 | GYRE | Gyre Therapeutics, Inc. | 728.94M | -1.72% | 30,634 | 107.27M |
| 195 | FULC | Fulcrum Therapeutics, Inc. | 708.41M | 0.77% | 1,120,836 | 80.00M |
| 196 | MGTX | MeiraGTx Holdings plc | 697.95M | 0.13% | 91,384 | 27.42M |
| 197 | LXEO | Lexeo Therapeutics, Inc. | 672.21M | -2.54% | 173,088 | - |
| 198 | CTMX | CytomX Therapeutics, Inc. | 667.58M | 1.81% | 380,022 | 113.63M |
| 199 | RGNX | REGENXBIO Inc. | 664.17M | -0.91% | 143,190 | 161.32M |
| 200 | PROK | ProKidney Corp. | 663.34M | -6.17% | 566,162 | 744.00K |
| 201 | CRVS | Corvus Pharmaceuticals, Inc. | 657.95M | 2.92% | 618,245 | - |
| 202 | DRUG | Bright Minds Biosciences Inc. | 642.93M | 0.99% | 12,725 | - |
| 203 | LYEL | Lyell Immunopharma, Inc. | 627.74M | 4.32% | 48,422 | 41.00K |
| 204 | JBIO | Jade Biosciences, Inc. | 621.29M | 0.19% | 30,059 | - |
| 205 | FDMT | 4D Molecular Therapeutics, Inc. | 615.63M | -2.75% | 218,996 | 120.00K |
| 206 | VTYX | Ventyx Biosciences, Inc. | 610.12M | -2.84% | 567,356 | - |
| 207 | ASMB | Assembly Biosciences, Inc. | 586.10M | 4.73% | 102,238 | 37.19M |
| 208 | IVVD | Invivyd, Inc. | 579.31M | 4.41% | 1,574,458 | 50.04M |
| 209 | ALT | Altimmune, Inc. | 574.93M | -1.78% | 2,621,372 | 20.00K |
| 210 | PRTA | Prothena Corporation plc | 568.44M | -1.58% | 151,369 | 11.79M |
| 211 | DBVT | DBV Technologies S.A. | 564.59M | 1.18% | 80,978 | 5.50M |
| 212 | EVMN | Evommune, Inc. | 560.34M | 1.03% | 54,884 | 3.00M |
| 213 | LBRX | LB Pharmaceuticals Inc | 551.27M | -3.16% | 96,322 | - |
| 214 | DSGN | Design Therapeutics, Inc. | 551.12M | -1.88% | 44,958 | - |
| 215 | DNA | Ginkgo Bioworks Holdings, Inc. | 545.06M | 2.02% | 436,640 | 180.61M |
| 216 | ENGN | enGene Holdings Inc. | 538.99M | -3.59% | 298,712 | - |
| 217 | ABSI | Absci Corporation | 536.83M | 3.48% | 1,121,723 | 2.82M |
| 218 | NAGE | Niagen Bioscience, Inc. | 522.58M | 0.54% | 173,026 | 124.71M |
| 219 | BCYC | Bicycle Therapeutics plc | 505.69M | -1.49% | 74,158 | 28.34M |
| 220 | MNPR | Monopar Therapeutics Inc. | 501.19M | -1.87% | 87,190 | - |
| 221 | ZVRA | Zevra Therapeutics, Inc. | 497.11M | 0.57% | 187,031 | 84.39M |
| 222 | LXRX | Lexicon Pharmaceuticals, Inc. | 481.50M | -4.68% | 1,144,772 | 70.86M |
| 223 | DMAC | DiaMedica Therapeutics Inc. | 468.18M | 2.63% | 255,259 | - |
| 224 | NBP | NovaBridge Biosciences | 462.22M | -0.25% | 163,713 | - |
| 225 | BNTC | Benitec Biopharma Inc. | 442.07M | -1.02% | 36,259 | - |
| 226 | SLDB | Solid Biosciences Inc. | 440.97M | -0.88% | 362,419 | - |
| 227 | KROS | Keros Therapeutics, Inc. | 423.50M | 1.78% | 155,267 | 246.72M |
| 228 | LCTX | Lineage Cell Therapeutics, Inc. | 422.86M | 3.25% | 218,303 | 10.82M |
| 229 | TENX | Tenax Therapeutics, Inc. | 421.93M | 0.97% | 119,762 | - |
| 230 | ENTA | Enanta Pharmaceuticals, Inc. | 411.29M | 0.49% | 40,564 | 65.32M |
| 231 | AURA | Aura Biosciences, Inc. | 408.33M | 0.47% | 18,951 | - |
| 232 | AUTL | Autolus Therapeutics plc | 405.87M | -4.09% | 1,240,937 | 51.13M |
| 233 | ANRO | Alto Neuroscience, Inc. | 405.73M | -5.64% | 135,072 | - |
| 234 | GALT | Galectin Therapeutics Inc. | 405.53M | 4.49% | 127,768 | - |
| 235 | ADCT | ADC Therapeutics SA | 405.08M | 1.55% | 283,421 | 75.21M |
| 236 | XOMA | XOMA Royalty Corporation | 401.15M | 6.25% | 39,486 | 47.11M |
| 237 | IMRX | Immuneering Corporation | 400.98M | -4.75% | 222,949 | - |
| 238 | PRTC | PureTech Health plc | 398.31M | 2.51% | 135 | 6.39M |
| 239 | AVXL | Anavex Life Sciences Corp. | 389.56M | 0.46% | 337,597 | - |
| 240 | PEPG | PepGen Inc. | 386.37M | 0.54% | 182,026 | - |
| 241 | TRDA | Entrada Therapeutics, Inc. | 385.15M | -2.72% | 29,582 | 61.52M |
| 242 | OCGN | Ocugen, Inc. | 379.47M | 1.25% | 1,257,759 | 5.37M |
| 243 | CTNM | Contineum Therapeutics, Inc. | 375.00M | 4.90% | 75,726 | - |
| 244 | RCKT | Rocket Pharmaceuticals, Inc. | 373.91M | -1.29% | 456,497 | - |
| 245 | TECX | Tectonic Therapeutic, Inc. | 373.20M | -0.35% | 45,202 | - |
| 246 | VTVT | vTv Therapeutics Inc. | 372.51M | -1.61% | 1,213 | 17.00K |
| 247 | VNDA | Vanda Pharmaceuticals Inc. | 369.65M | 1.87% | 491,057 | 212.07M |
| 248 | DRTS | Alpha Tau Medical Ltd. | 366.21M | 10.41% | 108,663 | - |
| 249 | FBRX | Forte Biosciences, Inc. | 361.18M | 2.61% | 41,880 | - |
| 250 | ACRS | Aclaris Therapeutics, Inc. | 358.08M | 0.76% | 356,639 | 15.74M |
| 251 | KYTX | Kyverna Therapeutics, Inc. | 357.16M | -1.39% | 126,160 | - |
| 252 | NMRA | Neumora Therapeutics, Inc. | 353.47M | -5.02% | 332,513 | - |
| 253 | MREO | Mereo BioPharma Group plc | 346.91M | 2.35% | 1,051,629 | 500.00K |
| 254 | AVTX | Avalo Therapeutics, Inc. | 344.55M | -2.26% | 88,449 | 192.00K |
| 255 | CLLS | Cellectis S.A. | 341.97M | -1.73% | 52,937 | 82.55M |
| 256 | LRMR | Larimar Therapeutics, Inc. | 334.23M | 2.23% | 301,125 | - |
| 257 | ALLO | Allogene Therapeutics, Inc. | 332.60M | 2.07% | 1,306,436 | 22.00K |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 322.64M | -3.91% | 515,484 | 33.98M |
| 259 | SLN | Silence Therapeutics plc | 316.47M | -3.04% | 49,735 | 25.83M |
| 260 | IMMP | Immutep Limited | 312.19M | -3.08% | 548,439 | 3.31M |
| 261 | NGNE | Neurogene Inc. | 311.81M | -2.23% | 33,832 | 925.00K |
| 262 | GUTS | Fractyl Health, Inc. | 311.09M | 1.79% | 1,664,091 | 3.00K |
| 263 | CADL | Candel Therapeutics, Inc. | 306.33M | 2.39% | 280,742 | - |
| 264 | EPRX | Eupraxia Pharmaceuticals Inc. | 302.87M | 1.17% | 10,998 | - |
| 265 | CYBN | Cybin Inc. | 297.43M | 0.85% | 150,294 | - |
| 266 | ALDX | Aldeyra Therapeutics, Inc. | 294.80M | -1.01% | 369,139 | - |
| 267 | TARA | Protara Therapeutics, Inc. | 294.30M | -0.35% | 290,916 | - |
| 268 | RLMD | Relmada Therapeutics, Inc. | 294.07M | -3.84% | 525,841 | - |
| 269 | PALI | Palisade Bio, Inc. | 290.56M | 7.73% | 2,132,557 | - |
| 270 | OABI | OmniAb, Inc. | 283.59M | -1.01% | 144,072 | 21.09M |
| 271 | ABEO | Abeona Therapeutics Inc. | 282.88M | 1.75% | 621,002 | 400.00K |
| 272 | AARD | Aardvark Therapeutics, Inc. | 282.62M | -6.08% | 127,489 | - |
| 273 | PBYI | Puma Biotechnology, Inc. | 278.66M | 2.41% | 157,985 | 212.00M |
| 274 | SLS | SELLAS Life Sciences Group, Inc. | 272.78M | 5.22% | 3,414,935 | - |
| 275 | ACIU | AC Immune SA | 271.10M | -1.44% | 48,627 | 5.48M |
| 276 | MIST | Milestone Pharmaceuticals Inc. | 270.21M | - | 2,388,666 | - |
| 277 | PYXS | Pyxis Oncology, Inc. | 269.60M | 3.59% | 137,052 | 2.82M |
| 278 | CBIO | Crescent Biopharma, Inc. | 261.77M | 1.67% | 141,954 | - |
| 279 | FENC | Fennec Pharmaceuticals Inc. | 260.76M | 1.26% | 28,442 | 38.79M |
| 280 | NAUT | Nautilus Biotechnology, Inc. | 257.66M | 0.49% | 91,513 | - |
| 281 | FHTX | Foghorn Therapeutics Inc. | 250.52M | -0.45% | 19,196 | 24.52M |
| 282 | CCCC | C4 Therapeutics, Inc. | 250.04M | 1.57% | 288,945 | 30.11M |
| 283 | ACHV | Achieve Life Sciences, Inc. | 249.53M | -0.05% | 171,333 | - |
| 284 | AVIR | Atea Pharmaceuticals, Inc. | 247.27M | -1.09% | 114,504 | - |
| 285 | ZURA | Zura Bio Limited | 247.09M | 0.80% | 68,186 | - |
| 286 | HRTX | Heron Therapeutics, Inc. | 245.71M | -0.74% | 482,167 | 155.10M |
| 287 | CABA | Cabaletta Bio, Inc. | 243.55M | 2.02% | 930,354 | - |
| 288 | OBIO | Orchestra BioMed Holdings, Inc. | 243.36M | -1.82% | 73,126 | 2.82M |
| 289 | HUMA | Humacyte, Inc. | 241.58M | - | 3,202,654 | 1.57M |
| 290 | PRQR | ProQR Therapeutics N.V. | 241.24M | 8.02% | 266,688 | 18.86M |
| 291 | EDIT | Editas Medicine, Inc. | 241.12M | 2.07% | 530,218 | 46.38M |
| 292 | MDWD | MediWound Ltd. | 239.12M | 0.76% | 18,124 | 20.93M |
| 293 | VYGR | Voyager Therapeutics, Inc. | 239.08M | -0.46% | 103,883 | 31.32M |
| 294 | TNXP | Tonix Pharmaceuticals Holding Corp. | 236.89M | 1.13% | 289,495 | 10.30M |
| 295 | TNYA | Tenaya Therapeutics, Inc. | 232.28M | 0.36% | 446,123 | - |
| 296 | IMMX | Immix Biopharma, Inc. | 231.18M | 11.95% | 1,540,063 | - |
| 297 | ETHZ | ETHZilla Corporation | 225.88M | 5.89% | 430,684 | 4.11M |
| 298 | VOR | Vor Biopharma Inc. | 220.84M | 29.43% | 27,026,205 | - |
| 299 | ARMP | Armata Pharmaceuticals, Inc. | 215.80M | 8.00% | 10,665 | 5.05M |
| 300 | QNCX | Quince Therapeutics, Inc. | 214.37M | -1.28% | 221,105 | - |
| 301 | ARCT | Arcturus Therapeutics Holdings Inc. | 208.26M | -1.61% | 206,867 | 97.60M |
| 302 | SGMT | Sagimet Biosciences Inc. | 207.16M | 2.91% | 193,870 | - |
| 303 | RNAC | Cartesian Therapeutics, Inc. | 205.43M | 17.56% | 446,943 | 1.09M |
| 304 | TLSA | Tiziana Life Sciences Ltd | 199.62M | 0.60% | 199,967 | - |
| 305 | STTK | Shattuck Labs, Inc. | 196.17M | 2.99% | 92,575 | 1.00M |
| 306 | NBY | NovaBay Pharmaceuticals, Inc. | 193.43M | -0.97% | 250,342 | 10.30M |
| 307 | SRZN | Surrozen, Inc. | 192.00M | 9.43% | 59,907 | 3.60M |
| 308 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 191.58M | -0.29% | 34,652 | - |
| 309 | RANI | Rani Therapeutics Holdings, Inc. | 190.77M | 0.64% | 826,871 | 1.20M |
| 310 | NVCT | Nuvectis Pharma, Inc. | 182.12M | 6.92% | 119,282 | - |
| 311 | IPHA | Innate Pharma S.A. | 177.74M | -0.53% | 7,106 | 14.84M |
| 312 | CRBU | Caribou Biosciences, Inc. | 177.12M | 0.26% | 315,763 | 9.30M |
| 313 | SABS | SAB Biotherapeutics, Inc. | 177.10M | 4.79% | 87,747 | 114.70K |
| 314 | VTGN | Vistagen Therapeutics, Inc. | 176.94M | 4.43% | 317,042 | 721.00K |
| 315 | NTHI | NeOnc Technologies Holdings, Inc. | 174.88M | -1.21% | 29,206 | 59.99K |
| 316 | IKT | Inhibikase Therapeutics, Inc. | 174.51M | 3.47% | 41,008 | 1.00 |
| 317 | CDXS | Codexis, Inc. | 172.52M | -0.52% | 185,620 | 52.93M |
| 318 | CAMP | Camp4 Therapeutics Corporation | 171.58M | 0.27% | 31,075 | 3.80M |
| 319 | SGMO | Sangamo Therapeutics, Inc. | 171.34M | 1.01% | 1,345,161 | 32.88M |
| 320 | GNLX | Genelux Corporation | 170.98M | 4.00% | 51,722 | 8.00K |
| 321 | ACTU | Actuate Therapeutics, Inc. | 170.61M | -2.00% | 18,038 | - |
| 322 | ANIX | Anixa Biosciences, Inc. | 169.03M | -1.63% | 244,501 | - |
| 323 | CRDF | Cardiff Oncology, Inc. | 167.05M | 5.98% | 1,150,591 | 501.00K |
| 324 | IRD | Opus Genetics, Inc. | 166.20M | 5.24% | 295,805 | 14.63M |
| 325 | CGEN | Compugen Ltd. | 158.54M | 9.35% | 313,975 | 6.90M |
| 326 | BDTX | Black Diamond Therapeutics, Inc. | 157.82M | 0.73% | 445,903 | 70.00M |
| 327 | CHRS | Coherus Oncology, Inc. | 155.92M | 0.78% | 353,512 | 277.73M |
| 328 | MOLN | Molecular Partners AG | 155.27M | -1.28% | 1,415 | 856.30K |
| 329 | SAVA | Cassava Sciences, Inc. | 154.59M | - | 200,348 | - |
| 330 | CGTX | Cognition Therapeutics, Inc. | 154.48M | - | 219,479 | - |
| 331 | MCRB | Seres Therapeutics, Inc. | 152.84M | -1.66% | 41,957 | 351.00K |
| 332 | INO | Inovio Pharmaceuticals, Inc. | 148.40M | 3.35% | 731,323 | 182.34K |
| 333 | GANX | Gain Therapeutics, Inc. | 146.78M | 1.50% | 838,280 | - |
| 334 | UNCY | Unicycive Therapeutics, Inc. | 145.28M | 2.74% | 189,862 | - |
| 335 | ELTX | Elicio Therapeutics, Inc. | 143.47M | -2.67% | 95,173 | - |
| 336 | KLRS | Kalaris Therapeutics, Inc. | 143.26M | 24.35% | 134,788 | - |
| 337 | PLX | Protalix BioTherapeutics, Inc. | 141.54M | 1.15% | 209,042 | 61.84M |
| 338 | MRSN | Mersana Therapeutics, Inc. | 139.32M | -0.18% | 21,330 | 33.18M |
| 339 | VRCA | Verrica Pharmaceuticals Inc. | 137.83M | 6.29% | 82,980 | 30.83M |
| 340 | AGEN | Agenus Inc. | 135.35M | -1.24% | 195,975 | 106.83M |
| 341 | GLSI | Greenwich LifeSciences, Inc. | 133.97M | 0.62% | 52,907 | - |
| 342 | ALEC | Alector, Inc. | 133.16M | - | 681,088 | 69.05M |
| 343 | PRLD | Prelude Therapeutics Incorporated | 132.66M | 10.27% | 250,119 | 10.50M |
| 344 | CNTB | Connect Biopharma Holdings Limited | 132.49M | -1.66% | 23,495 | 762.00K |
| 345 | ACOG | Alpha Cognition Inc. | 132.08M | 1.08% | 39,425 | 7.43M |
| 346 | NKTX | Nkarta, Inc. | 131.40M | 1.09% | 280,884 | - |
| 347 | COYA | Coya Therapeutics, Inc. | 130.57M | 2.80% | 83,221 | 3.99M |
| 348 | SPRO | Spero Therapeutics, Inc. | 129.86M | -0.22% | 204,716 | 40.55M |
| 349 | CLYM | Climb Bio, Inc. | 128.53M | 4.14% | 328,848 | - |
| 350 | FATE | Fate Therapeutics, Inc. | 122.85M | -0.47% | 290,234 | 7.14M |
| 351 | EXOZ | eXoZymes, Inc. | 121.62M | 2.69% | 540 | -700.00 |
| 352 | ANVS | Annovis Bio, Inc. | 120.46M | 5.70% | 399,110 | - |
| 353 | ELDN | Eledon Pharmaceuticals, Inc. | 119.49M | - | 237,281 | - |
| 354 | WHWK | Whitehawk Therapeutics, Inc. | 118.53M | 5.23% | 25,230 | 14.38M |
| 355 | OVID | Ovid Therapeutics Inc. | 116.79M | 3.80% | 473,747 | 6.61M |
| 356 | DTIL | Precision BioSciences, Inc. | 116.27M | 1.47% | 119,612 | 698.00K |
| 357 | ABOS | Acumen Pharmaceuticals, Inc. | 116.00M | -1.29% | 9,269 | - |
| 358 | ATRA | Atara Biotherapeutics, Inc. | 114.43M | 5.24% | 29,702 | 151.93M |
| 359 | SLGL | Sol-Gel Technologies Ltd. | 113.52M | -2.95% | 9,063 | 18.97M |
| 360 | VANI | Vivani Medical, Inc. | 110.89M | 4.83% | 55,563 | - |
| 361 | CNTX | Context Therapeutics Inc. | 110.85M | -1.89% | 166,075 | - |
| 362 | ORMP | Oramed Pharmaceuticals Inc. | 108.26M | 1.12% | 15,660 | 2.00M |
| 363 | KPTI | Karyopharm Therapeutics Inc. | 104.86M | 4.41% | 119,520 | 142.53M |
| 364 | ATOS | Atossa Therapeutics, Inc. | 104.51M | 3.52% | 236,240 | - |
| 365 | SEER | Seer, Inc. | 103.21M | - | 13,071 | 16.38M |
| 366 | ONCY | Oncolytics Biotech Inc. | 101.90M | 1.62% | 104,907 | - |
| 367 | ZNTL | Zentalis Pharmaceuticals, Inc. | 100.79M | -1.06% | 197,786 | 26.87M |
| 368 | SPRB | Spruce Biosciences, Inc. | 100.52M | 14.97% | 48,943 | 697.00K |
| 369 | BMEA | Biomea Fusion, Inc. | 98.63M | 3.33% | 687,101 | - |
| 370 | TTRX | Turn Therapeutics Inc. | 97.17M | -2.08% | 11,953 | - |
| 371 | ENTX | Entera Bio Ltd. | 96.30M | -1.41% | 37,950 | 124.00K |
| 372 | ADVM | Adverum Biotechnologies, Inc. | 96.26M | - | - | 1.00M |
| 373 | ANEB | Anebulo Pharmaceuticals, Inc. | 95.32M | 2.20% | 4,845 | - |
| 374 | RPTX | Repare Therapeutics Inc. | 93.60M | 1.28% | 58,529 | 11.87M |
| 375 | OTLK | Outlook Therapeutics, Inc. | 92.61M | 4.25% | 865,741 | 1.51M |
| 376 | THAR | Tharimmune, Inc. | 92.17M | 4.37% | 121,657 | - |
| 377 | PSTV | Plus Therapeutics, Inc. | 91.57M | 5.76% | 3,266,124 | 5.26M |
| 378 | FBIO | Fortress Biotech, Inc. | 91.41M | 1.90% | 106,208 | 62.30M |
| 379 | ADAG | Adagene Inc. | 90.96M | -3.02% | 11,623 | 103.20K |
| 380 | HYFT | MindWalk Holdings Corp. | 90.92M | 2.07% | 44,129 | 18.21M |
| 381 | CBUS | Cibus, Inc. | 89.57M | 3.77% | 119,980 | 3.79M |
| 382 | TVGN | Tevogen Bio Holdings Inc. | 89.41M | 3.23% | 15,812,092 | - |
| 383 | MGNX | MacroGenics, Inc. | 87.93M | 4.51% | 377,054 | 127.63M |
| 384 | VXRT | Vaxart, Inc. | 87.32M | -0.41% | 32,717 | 148.20M |
| 385 | CSBR | Champions Oncology, Inc. | 87.00M | 0.80% | 430 | 56.88M |
| 386 | PTHS | Pelthos Therapeutics Inc. | 86.92M | 3.80% | 3,001 | 7.41M |
| 387 | ACET | Adicet Bio, Inc. | 86.11M | 1.58% | 1,041,858 | - |
| 388 | COEP | Coeptis Therapeutics Holdings, Inc. | 85.33M | 3.77% | 44,154 | 501.00K |
| 389 | BYSI | BeyondSpring Inc. | 84.30M | 3.54% | 11,831 | 1.88M |
| 390 | IMUX | Immunic, Inc. | 81.29M | 0.95% | 421,052 | - |
| 391 | CRVO | CervoMed Inc. | 81.15M | -0.23% | 9,873 | 6.16M |
| 392 | ATYR | aTyr Pharma, Inc. | 80.99M | 1.76% | 389,128 | 190.00K |
| 393 | ALXO | ALX Oncology Holdings Inc. | 80.78M | 3.47% | 58,544 | - |
| 394 | PLRX | Pliant Therapeutics, Inc. | 80.50M | 2.34% | 546,527 | - |
| 395 | ACRV | Acrivon Therapeutics, Inc. | 80.47M | 1.19% | 380,676 | - |
| 396 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 80.25M | 11.65% | 6,641,999 | - |
| 397 | ESLA | Estrella Immunopharma, Inc. | 77.42M | - | 35,964 | - |
| 398 | ARTV | Artiva Biotherapeutics, Inc. | 75.55M | -0.06% | 67,333 | 251.00K |
| 399 | MNOV | MediciNova, Inc. | 75.29M | 1.66% | 25,998 | 257.92K |
| 400 | TIL | Instil Bio, Inc. | 74.47M | -1.17% | 11,731 | - |
| 401 | IFRX | InflaRx N.V. | 74.33M | 3.50% | 218,052 | 73.73K |
| 402 | OKYO | OKYO Pharma Limited | 73.25M | 1.96% | 6,722 | - |
| 403 | XBIT | XBiotech Inc. | 73.17M | -1.64% | 41,773 | - |
| 404 | STRO | Sutro Biopharma, Inc. | 71.68M | -0.88% | 14,962 | 105.65M |
| 405 | OSTX | OS Therapies Incorporated | 69.55M | 0.77% | 261,993 | - |
| 406 | IMA | ImageneBio, Inc. | 69.12M | -0.76% | 7,019 | 800.00K |
| 407 | MGX | Metagenomi, Inc. | 68.34M | 0.55% | 75,244 | 30.91M |
| 408 | KRRO | Korro Bio, Inc. | 68.18M | -3.98% | 144,663 | 7.37M |
| 409 | PMVP | PMV Pharmaceuticals, Inc. | 67.58M | 8.55% | 156,631 | - |
| 410 | ALGS | Aligos Therapeutics, Inc. | 67.57M | 1.86% | 13,570 | 2.65M |
| 411 | PYPD | PolyPid Ltd. | 66.54M | 0.50% | 63,698 | - |
| 412 | NRXP | NRx Pharmaceuticals, Inc. | 66.31M | 4.42% | 185,739 | 242.00K |
| 413 | LITS | Lite Strategy, Inc. | 65.11M | 2.91% | 123,949 | - |
| 414 | ATHE | Alterity Therapeutics Limited | 64.79M | 0.30% | 2,826 | 3.57M |
| 415 | CALC | CalciMedica, Inc. | 64.27M | 1.13% | 10,817 | - |
| 416 | HURA | TuHURA Biosciences, Inc. | 63.56M | -37.37% | 1,408,538 | - |
| 417 | IOBT | IO Biotech, Inc. | 60.73M | 12.29% | 897,713 | - |
| 418 | INMB | INmune Bio, Inc. | 59.82M | 10.29% | 563,466 | 50.00K |
| 419 | NTRB | Nutriband Inc. | 59.74M | 0.64% | 5,209 | 2.58M |
| 420 | TCRX | TScan Therapeutics, Inc. | 58.73M | 3.50% | 282,018 | 8.42M |
| 421 | PDSB | PDS Biotechnology Corporation | 56.91M | 15.77% | 1,442,866 | - |
| 422 | INKT | MiNK Therapeutics, Inc. | 56.85M | 0.83% | 15,430 | - |
| 423 | EVAX | Evaxion A/S | 56.71M | 8.76% | 222,897 | 7.65M |
| 424 | EQ | Equillium, Inc. | 56.49M | 6.10% | 110,251 | 4.39M |
| 425 | IBO | Impact BioMedical Inc. | 55.21M | 4.97% | 60,476 | 25.00K |
| 426 | SNTI | Senti Biosciences, Inc. | 53.11M | -15.48% | 62,469,935 | - |
| 427 | ABVC | ABVC BioPharma, Inc. | 52.56M | 5.19% | 26,757 | 797.92K |
| 428 | CELU | Celularity Inc. | 50.99M | -4.76% | 33,159 | 40.58M |
| 429 | CVM | CEL-SCI Corporation | 50.98M | 1.44% | 7,546 | - |
| 430 | ICCC | ImmuCell Corporation | 50.89M | 2.65% | 4,565 | 27.77M |
| 431 | IPSC | Century Therapeutics, Inc. | 50.80M | 2.07% | 237,360 | 113.34M |
| 432 | MAIA | MAIA Biotechnology, Inc. | 50.73M | 11.38% | 743,273 | - |
| 433 | GRCE | Grace Therapeutics, Inc. | 48.99M | 3.50% | 76,042 | - |
| 434 | HOWL | Werewolf Therapeutics, Inc. | 48.54M | -0.01% | 111,472 | 1.14M |
| 435 | JSPR | Jasper Therapeutics, Inc. | 48.41M | 0.58% | 281,866 | - |
| 436 | TELO | Telomir Pharmaceuticals, Inc. | 48.31M | -0.35% | 67,666 | - |
| 437 | BTAI | BioXcel Therapeutics, Inc. | 48.00M | -0.23% | 138,465 | 752.00K |
| 438 | BCAB | BioAtla, Inc. | 47.12M | -1.05% | 295,798 | 11.00M |
| 439 | IBIO | iBio, Inc. | 46.77M | 24.55% | 36,584,481 | 500.00K |
| 440 | KZR | Kezar Life Sciences, Inc. | 45.84M | -0.32% | 5,944 | - |
| 441 | OKUR | OnKure Therapeutics, Inc. | 45.18M | -2.49% | 49,809 | - |
| 442 | XCUR | Exicure, Inc. | 44.30M | 30.39% | 26,943,242 | 500.00K |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 44.30M | 1.42% | 61,499 | 90.00K |
| 444 | LTRN | Lantern Pharma Inc. | 43.84M | 1.82% | 33,943 | - |
| 445 | CUE | Cue Biopharma, Inc. | 41.73M | 0.32% | 209,263 | 7.10M |
| 446 | GNTA | Genenta Science S.p.A. | 41.47M | -2.21% | 64,090 | - |
| 447 | VERU | Veru Inc. | 41.41M | -2.64% | 53,961 | 16.89M |
| 448 | QTTB | Q32 Bio Inc. | 40.54M | -4.77% | 167,939 | - |
| 449 | JUNS | Jupiter Neurosciences, Inc. | 39.53M | 0.72% | 15,082 | - |
| 450 | TVRD | Tvardi Therapeutics, Inc. | 39.12M | -0.24% | 38,207 | - |
| 451 | ANL | Adlai Nortye Ltd. | 39.11M | 20.45% | 67,927 | 1.94M |
| 452 | SKYE | Skye Bioscience, Inc. | 39.11M | 0.83% | 56,433 | - |
| 453 | QNTM | Quantum BioPharma Ltd. | 38.59M | 1.58% | 34,180 | - |
| 454 | RNTX | Rein Therapeutics Inc. | 38.16M | 4.43% | 30,008 | - |
| 455 | XLO | Xilio Therapeutics, Inc. | 38.15M | -0.45% | 347,715 | 31.80M |
| 456 | APLM | Apollomics, Inc. | 37.75M | 5.27% | 16,837 | 198.00K |
| 457 | NXTC | NextCure, Inc. | 37.22M | -2.79% | 12,805 | - |
| 458 | GBIO | Generation Bio Co. | 36.38M | 2.08% | 17,078 | 15.27M |
| 459 | DYAI | Dyadic International, Inc. | 36.04M | 0.61% | 8,445 | 3.34M |
| 460 | RNXT | RenovoRx, Inc. | 35.41M | 2.55% | 91,196 | 928.00K |
| 461 | RADX | Radiopharm Theranostics Limited | 35.13M | 0.41% | 21,440 | 8.20M |
| 462 | SER | Serina Therapeutics, Inc. | 35.02M | -1.09% | 8,779 | 116.00K |
| 463 | APLT | Applied Therapeutics, Inc. | 34.96M | 10.14% | 3,020,892 | 1.00M |
| 464 | FGEN | FibroGen, Inc. | 34.43M | 1.79% | 6,808 | 8.30M |
| 465 | GLTO | Galecto, Inc. | 34.24M | 0.27% | 54,495 | - |
| 466 | KLTO | Klotho Neurosciences, Inc. | 32.57M | -0.34% | 417,970 | - |
| 467 | PASG | Passage Bio, Inc. | 32.45M | 2.92% | 20,277 | - |
| 468 | PLUR | Pluri Inc. | 31.46M | 8.63% | 110,583 | 1.33M |
| 469 | ANTX | AN2 Therapeutics, Inc. | 31.38M | 4.09% | 19,166 | - |
| 470 | RLYB | Rallybio Corporation | 30.42M | 5.99% | 188,688 | 674.00K |
| 471 | KZIA | Kazia Therapeutics Limited | 30.14M | 4.52% | 77,253 | 1.20M |
| 472 | INTS | Intensity Therapeutics, Inc. | 30.14M | 0.06% | 815,870 | - |
| 473 | LNAI | Lunai Bioworks Inc. | 28.70M | -11.23% | 1,063,034 | - |
| 474 | NRXS | NeurAxis, Inc. | 28.66M | 2.28% | 3,189 | 3.36M |
| 475 | HYPD | Hyperion DeFi, Inc. | 28.51M | 6.99% | 202,048 | 345.32K |
| 476 | BRNS | Barinthus Biotherapeutics plc | 28.38M | -1.11% | 13,476 | 14.97M |
| 477 | IGC | IGC Pharma, Inc. | 27.63M | 2.30% | 227,146 | 1.11M |
| 478 | NERV | Minerva Neurosciences, Inc. | 26.64M | -1.55% | 21,251 | - |
| 479 | DARE | Daré Bioscience, Inc. | 26.36M | 0.27% | 10,381 | -57.13K |
| 480 | CING | Cingulate Inc. | 26.08M | -1.53% | 39,370 | - |
| 481 | KTTA | Pasithea Therapeutics Corp. | 25.98M | 2.65% | 271,946 | - |
| 482 | CLGN | CollPlant Biotechnologies Ltd. | 25.55M | -1.96% | 1,265 | 2.48M |
| 483 | BOLD | Boundless Bio, Inc. | 25.29M | -0.88% | 32,311 | - |
| 484 | ENLV | Enlivex Therapeutics Ltd. | 25.14M | -5.91% | 622,278 | - |
| 485 | LEXX | Lexaria Bioscience Corp. | 25.04M | 3.38% | 50,255 | 705.92K |
| 486 | NNVC | NanoViricides, Inc. | 24.84M | -3.50% | 301,515 | - |
| 487 | LIXT | Lixte Biotechnology Holdings, Inc. | 24.76M | - | 37,569 | - |
| 488 | MRKR | Marker Therapeutics, Inc. | 24.43M | 3.17% | 158,579 | 4.69M |
| 489 | NEUP | Neuphoria Therapeutics Inc. | 24.36M | -0.22% | 11,322 | 15.65M |
| 490 | NRSN | NeuroSense Therapeutics Ltd. | 23.96M | -3.36% | 337,102 | - |
| 491 | ITRM | Iterum Therapeutics plc | 23.75M | 0.40% | 83,847 | 390.00K |
| 492 | BCTX | BriaCell Therapeutics Corp. | 23.66M | 2.79% | 27,555 | - |
| 493 | LIMN | Liminatus Pharma, Inc. | 23.10M | -1.23% | 48,348 | - |
| 494 | PTN | Palatin Technologies, Inc. | 22.39M | 2.90% | 3,052 | 8.85M |
| 495 | CTXR | Citius Pharmaceuticals, Inc. | 21.80M | 5.36% | 261,360 | - |
| 496 | PLRZ | Polyrizon Ltd. | 21.67M | -0.63% | 257,587 | - |
| 497 | APVO | Aptevo Therapeutics Inc. | 20.89M | -7.46% | 1,547,595 | - |
| 498 | CVKD | Cadrenal Therapeutics, Inc. | 20.76M | 0.70% | 17,132 | - |
| 499 | GDTC | CytoMed Therapeutics Limited | 19.52M | -8.55% | 42,126 | 573.19K |
| 500 | MTVA | MetaVia Inc. | 18.93M | -25.35% | 141,869 | - |
| 501 | TRAW | Traws Pharma, Inc. | 18.92M | 9.64% | 60,635 | 2.85M |
| 502 | HOTH | Hoth Therapeutics, Inc. | 18.38M | 2.11% | 33,658 | - |
| 503 | CASI | CASI Pharmaceuticals, Inc. | 18.26M | -4.45% | 38,187 | 26.85M |
| 504 | LPCN | Lipocine Inc. | 18.20M | 0.24% | 1,498 | 4.32M |
| 505 | ALLR | Allarity Therapeutics, Inc. | 18.18M | -0.86% | 217,780 | - |
| 506 | OSRH | OSR Holdings, Inc. | 18.07M | -2.48% | 240,505 | -90.52K |
| 507 | LSTA | Lisata Therapeutics, Inc. | 17.92M | 4.17% | 7,088 | 1.07M |
| 508 | KAPA | Kairos Pharma, Ltd. | 17.80M | -1.61% | 56,622 | - |
| 509 | NCNA | NuCana plc | 17.65M | 2.42% | 25,462 | - |
| 510 | NCEL | NewcelX Ltd. | 17.41M | -1.29% | 34,191 | - |
| 511 | CRIS | Curis, Inc. | 17.32M | -0.74% | 71,843 | 11.65M |
| 512 | FBLG | FibroBiologics, Inc. | 16.76M | -1.23% | 425,972 | - |
| 513 | PMN | ProMIS Neurosciences, Inc. | 16.72M | 1.97% | 7,022 | - |
| 514 | CLRB | Cellectar Biosciences, Inc. | 16.49M | -2.26% | 11,936 | - |
| 515 | SNGX | Soligenix, Inc. | 16.34M | 2.53% | 51,986 | 2.34K |
| 516 | PULM | Pulmatrix, Inc. | 16.25M | 10.97% | 1,086 | 3.00K |
| 517 | PCSA | Processa Pharmaceuticals, Inc. | 16.18M | 0.56% | 176,305 | - |
| 518 | CANF | Can-Fite BioPharma Ltd. | 15.80M | -4.43% | 426,259 | 560.00K |
| 519 | TPST | Tempest Therapeutics, Inc. | 15.72M | 2.57% | 50,614 | - |
| 520 | BCDA | BioCardia, Inc. | 15.49M | 2.10% | 16,542 | 3.00K |
| 521 | ABP | Abpro Holdings, Inc. | 15.48M | 1.97% | 3,731 | 183.00K |
| 522 | CMMB | Chemomab Therapeutics Ltd. | 15.39M | -8.76% | 62,467 | - |
| 523 | ATHA | Athira Pharma, Inc. | 15.18M | -0.77% | 2,307 | - |
| 524 | COCP | Cocrystal Pharma, Inc. | 14.61M | 0.95% | 15,355 | - |
| 525 | MBRX | Moleculin Biotech, Inc. | 13.95M | -5.52% | 2,035,581 | - |
| 526 | DWTX | Dogwood Therapeutics, Inc. | 13.78M | 0.22% | 22,202 | - |
| 527 | BLRX | BioLineRx Ltd. | 13.77M | -0.60% | 7,630 | 12.74M |
| 528 | VYNE | VYNE Therapeutics Inc. | 12.72M | 2.25% | 244,996 | 524.00K |
| 529 | ICU | SeaStar Medical Holding Corporation | 12.63M | 3.33% | 422,284 | 881.00K |
| 530 | LGVN | Longeveron Inc. | 12.58M | -0.52% | 177,649 | 1.44M |
| 531 | SYBX | Synlogic, Inc. | 12.40M | 1.92% | 8,343 | 8.00K |
| 532 | PHIO | Phio Pharmaceuticals Corp. | 12.33M | 1.33% | 485,251 | - |
| 533 | IMNN | Imunon, Inc. | 12.16M | 1.54% | 2,442 | - |
| 534 | AKTX | Akari Therapeutics, Plc | 12.11M | -0.32% | 5,433,771 | - |
| 535 | EDSA | Edesa Biotech, Inc. | 12.10M | -1.15% | 9,406 | - |
| 536 | BIVI | BioVie Inc. | 12.02M | 0.31% | 52,587 | - |
| 537 | GOVX | GeoVax Labs, Inc. | 11.82M | -3.49% | 447,267 | 3.35M |
| 538 | APM | Aptorum Group Limited | 11.16M | 3.42% | 7,928 | - |
| 539 | IMRN | Immuron Limited | 11.04M | 2.04% | 65,052 | 4.78M |
| 540 | PPCB | Propanc Biopharma, Inc. | 11.02M | -1.38% | 7,114 | - |
| 541 | CLDI | Calidi Biotherapeutics, Inc. | 10.98M | 2.04% | 25,898 | - |
| 542 | BOLT | Bolt Biotherapeutics, Inc. | 10.70M | 3.79% | 38,830 | 5.20M |
| 543 | ERNA | Ernexa Therapeutics Inc. | 10.67M | 4.62% | 16,204 | 1,000.00 |
| 544 | QNRX | Quoin Pharmaceuticals, Ltd. | 10.19M | -19.27% | 128,857 | - |
| 545 | BRTX | BioRestorative Therapies, Inc. | 10.03M | 4.63% | 2,539 | 383.40K |
| 546 | SNSE | Sensei Biotherapeutics, Inc. | 9.98M | -4.00% | 37,182 | - |
| 547 | ASBP | Aspire Biopharma Holdings, Inc. | 9.71M | -0.77% | 5,353,603 | 1.94K |
| 548 | EVGN | Evogene Ltd. | 9.52M | -3.48% | 18,464 | 8.02M |
| 549 | SLXN | Silexion Therapeutics Corp | 9.50M | -0.98% | 14,013 | - |
| 550 | MBIO | Mustang Bio, Inc. | 9.23M | 1.20% | 73,308 | - |
| 551 | AEON | AEON Biopharma, Inc. | 9.00M | -0.01% | 31,222 | - |
| 552 | TCRT | Alaunos Therapeutics, Inc. | 8.97M | -1.71% | 97,135 | 6.00K |
| 553 | ACXP | Acurx Pharmaceuticals, Inc. | 8.61M | -6.76% | 47,503 | - |
| 554 | ALZN | Alzamend Neuro, Inc. | 8.50M | -0.67% | 13,786 | - |
| 555 | CELZ | Creative Medical Technology Holdings, Inc. | 8.21M | 0.09% | 17,571 | 6.00K |
| 556 | XTLB | XTL Biopharmaceuticals Ltd. | 8.20M | -0.26% | 5,526 | 451.00K |
| 557 | BGMS | Bio Green Med Solution, Inc. | 8.18M | -2.62% | 990 | 81.00K |
| 558 | INAB | IN8bio, Inc. | 8.06M | -2.25% | 19,981 | - |
| 559 | GRDX | GridAI Technologies Corp. | 7.93M | -1.26% | 10,262 | - |
| 560 | PMCB | PharmaCyte Biotech, Inc. | 7.75M | -0.87% | 939,193 | - |
| 561 | RNAZ | TransCode Therapeutics, Inc. | 7.72M | 0.81% | 4,075 | - |
| 562 | ADXN | Addex Therapeutics Ltd | 7.65M | -3.11% | 332 | 198.82K |
| 563 | KPRX | Kiora Pharmaceuticals, Inc. | 7.63M | 0.48% | 6,090 | 20.00K |
| 564 | GNPX | Genprex, Inc. | 7.61M | -1.18% | 68,359 | - |
| 565 | PPBT | Purple Biotech Ltd | 7.50M | -0.21% | 46,478 | - |
| 566 | TOVX | Theriva Biologics, Inc. | 7.40M | -0.81% | 691,068 | - |
| 567 | LYRA | Lyra Therapeutics, Inc. | 7.37M | 4.53% | 26,354 | 600.00K |
| 568 | ADIL | Adial Pharmaceuticals, Inc. | 7.29M | -0.23% | 86,639 | - |
| 569 | GTBP | GT Biopharma, Inc. | 6.99M | 1.25% | 322,107 | - |
| 570 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.85M | 4.77% | 20,713 | 15.78K |
| 571 | KALA | KALA BIO, Inc. | 6.65M | -3.35% | 1,368,270 | - |
| 572 | CYCN | Cyclerion Therapeutics, Inc. | 6.47M | 0.59% | 3,681 | 2.86M |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 6.41M | -3.31% | 138,390 | - |
| 574 | REVB | Revelation Biosciences, Inc. | 6.39M | 2.29% | 21,625 | - |
| 575 | MTNB | Matinas BioPharma Holdings, Inc. | 6.25M | 9.00% | 10,346 | - |
| 576 | VIVS | VivoSim Labs, Inc. | 6.19M | -0.63% | 3,642 | 140.00K |
| 577 | APRE | Aprea Therapeutics, Inc. | 6.12M | -6.73% | 148,344 | 488.24K |
| 578 | SILO | Silo Pharma, Inc. | 5.80M | -4.20% | 43,391 | 72.10K |
| 579 | XBIO | Xenetic Biosciences, Inc. | 5.60M | 0.18% | 9,153 | 2.86M |
| 580 | HCWB | HCW Biologics Inc. | 5.24M | -1.52% | 10,418 | 422.03K |
| 581 | ENSC | Ensysce Biosciences, Inc. | 5.18M | -10.94% | 5,473,079 | 4.49M |
| 582 | JAGX | Jaguar Health, Inc. | 4.92M | 9.09% | 62,844 | 11.79M |
| 583 | SLRX | Salarius Pharmaceuticals, Inc. | 4.90M | 0.73% | 59,550 | - |
| 584 | INDP | Indaptus Therapeutics, Inc. | 4.64M | 1.52% | 132,398 | - |
| 585 | ONCO | Onconetix, Inc. | 4.60M | 5.36% | 3,970 | 1.22M |
| 586 | GRI | GRI Bio, Inc. | 4.54M | 2.96% | 708,037 | - |
| 587 | CNSP | CNS Pharmaceuticals, Inc. | 4.34M | -2.91% | 1,657 | - |
| 588 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.23M | 2.04% | 10,813 | 1.36M |
| 589 | XRTX | XORTX Therapeutics Inc. | 4.21M | -0.05% | 8,889 | - |
| 590 | PHGE | BiomX Inc. | 4.12M | -17.18% | 107,576 | - |
| 591 | OGEN | Oragenics, Inc. | 4.02M | -1.11% | 24,999 | - |
| 592 | AZTR | Azitra, Inc. | 4.01M | -2.76% | 66,909 | 7.50K |
| 593 | SCNI | Scinai Immunotherapeutics Ltd. | 3.98M | 5.04% | 85,025 | 1.15M |
| 594 | BDRX | Biodexa Pharmaceuticals Plc | 3.87M | -28.98% | 247,055 | 104.90K |
| 595 | ENVB | Enveric Biosciences, Inc. | 3.70M | 2.14% | 292,851 | - |
| 596 | ARTL | Artelo Biosciences, Inc. | 3.59M | -1.11% | 72,467 | - |
| 597 | SPRC | SciSparc Ltd. | 3.59M | 9.95% | 287,956 | 1.31M |
| 598 | ELAB | PMGC Holdings Inc. | 3.23M | -12.25% | 206,653 | 285.95K |
| 599 | PTIX | Protagenic Therapeutics, Inc. | 3.05M | -4.55% | 522,537 | - |
| 600 | PBM | Psyence Biomedical Ltd. | 3.01M | -4.73% | 14,588,675 | - |
| 601 | VRAX | Virax Biolabs Group Limited | 2.99M | -13.63% | 595,762 | 2.99K |
| 602 | DRMA | Dermata Therapeutics, Inc. | 2.93M | 2.89% | 92,161 | - |
| 603 | CDT | CDT Equity Inc. | 2.88M | -10.15% | 167,378 | - |
| 604 | CMND | Clearmind Medicine Inc. | 2.47M | -4.78% | 3,414,667 | - |
| 605 | ADTX | Aditxt, Inc. | 2.04M | 12.31% | 508,801 | 5.95K |
| 606 | MLEC | Moolec Science SA | 1.80M | 4.37% | 5,612 | 7.83M |